
When IVIG Improves Alzheimer’s, Does It Do Enough to Matter?
VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
Professional care for people with dementias such as Alzheimer’s is commonly referred to as “Long-Term Care”. 70% of people turning age 65 can expect to
VIDEOS & ARTICLE Watch videos on the newly released National Plan to Address Alzheimer’s Disease: 2013 Update. Read about the new timeline for achieving its first goal
A new experimental drug may rescue brain cells just as they begin to become impaired, stopping Alzheimer’s before it is even noticeable. Learn why researchers
Using Deep Brain Stimulation to treat Alzheimer’s is starting to take off. More patients are being added to clinical trials. Learn about the U.S. FDA’s
News on bexarotene demands explaining. In the Alzheimer’s lab, this FDA-approved anti-cancer drug improves memory. Since that is what matters to people, funding is pouring
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand
VIDEO If you live to 85, there’s a 50/50 chance of getting a dementia such as Alzheimer’s. What if you could improve those odds by
VIDEO Kathy Sanford is the first person in the USA to have a pacemaker implanted in her brain to treat Alzheimer’s. The pacemaker sends electronic
Dr. Francis Collins, director of the National Institutes of Health (NIH), just gave Americans a dose of good news on Alzheimer’s research. Find out what
MAUDE’S AWARDS RECOGNIZE AND REWARD INNOVATIVE CARE
FOR PERSONS LIVING WITH ALZHEIMER’S DISEASE. AWARD APPLICATIONS OPEN NOW!
A fascinating Smell-Test developed at Mass General Brigham may help determine your risk of developing Alzheimer’s.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.